Developer docs
API playgroundTry for free, no card

Search company profiles

ICU Medical

Full company profile

uuid0007ptf

Namestring
ICU Medical
Legal namestring
ICU Medical, Inc.
Websiteurl
icumed.com
Company typeenum
Public
Founded yearint
1984
Descriptiontext

ICU Medical, Inc. (NASDAQ: ICUI) is a publicly traded medical device company founded in 1984 and headquartered in San Clemente, California, that develops, manufactures, and sells innovative medical technologies used in infusion therapy, vascular access, and adjacent clinical care areas. The company's portfolio spans nine product categories: infusion therapy (Plum large-volume pumps, CADD ambulatory pumps, Medfusion syringe pumps, IV consumables, vascular access devices, IV solutions); pharmacy preparation (ChemoLock and ChemoClave closed system transfer devices, Diana compounding workflow, PharmAssist peristaltic pumps); infusion safety software (LifeShield, PharmGuard, MedNet); airway management (Portex, Bivona tracheostomy tubes, ventilation, anesthesia, respiratory); temperature management (Hotline and Level 1 blood/fluid warmers); hemodynamic monitoring (Cogent 2-in-1 system, CardioFlo sensors, SafeSet blood sampling); renal care (ClearGuard antimicrobial caps, Tego connectors); pain management (EchoGlo nerve block kits, NRFit components); and veterinary/OEM. The technical foundation centers on needlefree connector engineering (Clave family), closed system mechanical barrier technology for hazardous drug handling, and IV-EHR interoperable pump-software architecture under the IV Performance Platform. The combined entity following the January 2022 Smiths Medical acquisition (~$2.35B from Smiths Group) operates manufacturing and direct sales in nine countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersSan Clemente, United States
HQ citystring
San Clemente
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
infusion therapy devices, IV medical devices, vascular access products, medical consumables, clinical infusion pumps
Industry3 codes
1Infusion Pumps (Ambulatory/Stationary)
CodeHLAHAIAFPrimaryYes
2Infusion Sets, Catheters & Pump Consumables
CodeHLAHAIAHPrimaryNo
3Wearable Injectors & On-Body Delivery Systems
CodeHLAHAIAEPrimaryNo
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Medical Equipment and Supplies Manufacturing3391
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Medical Devices - Hardware Sales
TypeHardware Sales
Description

ICU Medical generates revenue from selling infusion pumps, IV equipment, vascular access devices, and other medical hardware. Products include Plum large-volume pumps, CADD ambulatory pumps, Medfusion syringe pumps, and related capital equipment.

icumed.com
2Single-Use Disposables and Consumables
TypeTransaction Fee
Description

The company derives significant revenue from recurring consumables including IV sets, connectors, disinfecting caps, administration sets, and other single-use products. Approximately 87% of revenue comes from single-use disposable items according to CEO presentation.

icumed.com
3Infusion Safety Software
TypeSubscription Recurring
Description

Revenue from software licenses including LifeShield Infusion Safety Software, PharmGuard Infusion Management System, and MedNet IV medication safety software for hospitals

icumed.com
4Temperature Management Products
TypeHardware Sales
Description

Sales of blood and fluid warming systems including Hotline products and Level 1 warming devices along with associated disposable sets

icumed.com
5IV Solutions
TypeManaged Services
Description

Following completion of joint venture with Otsuka in May 2025, the company participates in IV solutions manufacturing through the JV entity Otsuka ICU Medical LLC

globenewswire.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 14 records shown
1Plum
Description

Large-volume IV infusion pumps including Plum Duo and Plum Solo precision pumps

icumed.com
+13 more records
Core offering1 text field

ICU Medical develops, manufactures, and sells medical devices and consumables for infusion therapy, including large-volume IV pumps, ambulatory and syringe pumps, needlefree IV connectors, closed system transfer devices for hazardous drug handling, infusion safety software, temperature management systems, airway management products, hemodynamic monitoring systems, and renal care products. Approximately 87% of revenue comes from single-use disposable items, with the remaining from capital equipment and software licenses sold primarily to hospitals, health systems, and clinical facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 30% reduction in clinical medication errors through ready-to-administer formats
+3 more records
Product overview1 text field

ICU Medical offers a comprehensive, multi-category medical device portfolio organized into nine core product lines: Infusion Therapy (large-volume pumps, ambulatory pumps, syringe pumps, IV consumables, vascular access, IV solutions), Pharmacy Preparation (closed system transfer devices, compounding automation, infusion safety software), Airway Management (tracheostomy, respiratory, anesthesia, ventilation), Temperature Management (blood/fluid warmers, convective warming), Hemodynamic Monitoring (monitoring systems, sensors, blood pressure), Renal Care (antimicrobial caps, connectors), Pain Management (regional anesthesia, nerve blocks, spinal/epidural), Veterinary, and OEM. The flagship IV Performance Platform integrates Plum Duo™ and Plum Solo™ precision IV pumps with LifeShield™ software for IV-EHR interoperability. The company serves acute care, home care, pharmacy, and veterinary settings through both organic development and the 2022 Smiths Medical acquisition which expanded the portfolio with CADD pumps, Medfusion syringes, and Portex/Bivona airway products.

Product and service29 records
1Plum Solo Precision IV Pump
CategoryInfusion Pumps
2Plum Duo Precision IV Pump
CategoryInfusion Pumps
3Plum 360 Large Volume Infusion Pump
CategoryInfusion Pumps
4CADD-Solis Infusion System
CategoryAmbulatory Infusion Pumps
5CADD-Solis VIP Ambulatory Home Infusion System
CategoryAmbulatory Infusion Pumps
6Medfusion Syringe Pumps
CategorySyringe Infusion Pumps
7Clave Needlefree IV Connectors
CategoryIV Consumables
8ChemoLock Needlefree Closed System Transfer Device (CSTD)
CategoryClosed System Transfer Devices
9ChemoClave Needlefree Closed System Transfer Device (CSTD)
CategoryClosed System Transfer Devices
10Diana Compounding Workflow System
CategoryPharmacy Automation
11PharmAssist Pro Peristaltic Pump
CategoryPharmacy Automation
12LifeShield Infusion Safety Software
CategoryInfusion Safety Software
13ICU Medical MedNet IV Medication Safety Software
CategoryInfusion Safety Software
14PharmGuard Infusion Management System
CategoryInfusion Safety Software
15Level 1 H-1200 Fast Flow Fluid Warmer
CategoryTemperature Management
16Hotline 3 Blood and Fluid Warmer
CategoryTemperature Management
17Hotline Blood and Fluid Warmer
CategoryTemperature Management
18Portex BLUselect Tracheostomy Tubes
CategoryAirway Management
19Bivona Silicone Tracheostomy Tubes
CategoryAirway Management
20Cogent 2-in-1 Hemodynamic Monitoring System
CategoryHemodynamic Monitoring
21CardioFlo Hemodynamic Monitoring Sensor
CategoryHemodynamic Monitoring
22SafeSet Blood Sampling System
CategoryHemodynamic Monitoring
23ClearGuard HD Antimicrobial Barrier Caps
CategoryRenal Care
24Tego Needlefree Hemodialysis Connector
CategoryRenal Care
25EchoGlo Peripheral Nerve Block Kits and Trays
CategoryPain Management
26NRFit Components
CategoryPain Management
27MyAcapella Digital OPEP Coach
CategoryDigital Health Application
28IV Performance Platform
CategoryIntegrated Infusion Platform
29SurgiVet Advisor Tech Vital Signs Monitor
CategoryVeterinary
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

ICU Medical and Otsuka Pharmaceutical Factory completed a joint venture to bolster IV solutions manufacturing and innovation in North America. The partnership creates one of the largest global IV solutions manufacturing networks with combined production of approximately 1.4 billion annual units. The JV entity is named Otsuka ICU Medical LLC and aims to bring additional supply chain resiliency and new innovation to the North American IV solutions market.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BD is the largest direct competitor in IV therapy, vascular access, and infusion consumables. BD's Medical segment competes head-to-head with ICU Medical's Clave connectors, IV sets, and infusion platforms, making it the closest peer for share, scale, and pricing dynamics in hospital infusion.

TypeDirect peer
Description

Fresenius Kabi is a global manufacturer of infusion pumps (Agilia family), IV consumables, and specialty injectable drugs. It is a direct competitor to ICU Medical in hospital infusion and is increasingly expanding its pump and consumables portfolio in North America following its Ivenix acquisition.

TypeBroad incumbent
Description

Medtronic is a diversified medical device leader with limited overlap in infusion but a comparable scale, hospital-channel presence, and R&D footprint. It is a relevant broader incumbent for benchmarking margins, capital allocation, and global hospital sales execution.

TypeDirect peer
Description

B. Braun is a privately held global leader in infusion therapy (Infusomat pumps, IV sets, needlefree connectors) and competes directly with ICU Medical across infusion pumps, consumables, and pharmacy preparation. Its broad hospital-focused portfolio and global footprint make it a close comparable on scale and product breadth.

TypeDirect peer
Description

Terumo competes with ICU Medical in infusion systems (Terufusion), syringes, and vascular access. Its hospital-focused medical device business and growing presence in infusion safety software make it a strong comparable for ICU Medical's premium pump and consumables strategy.

TypeBroad incumbent
Description

Cardinal Health is a major medical product distributor and manufacturer with hospital channel reach. While it operates at a different layer of the value chain, it is comparable as a broad incumbent that supplies IV-related consumables and competes for hospital supply contracts.

TypeDirect peer
Description

Nipro manufactures infusion sets, syringes, dialysis products, and other hospital medical devices, overlapping directly with ICU Medical's IV consumables, renal care, and vascular access portfolios. Its scale and emerging US footprint make it a relevant direct peer.

TypeBroad incumbent
Description

Smiths Group divested Smiths Medical to ICU Medical in 2022, so it is no longer a direct peer in medical devices, but it remains comparable as the former parent of ICU Medical's largest business segment and as a UK-listed diversified industrial with medical exposure.

TypeDirect peer
Description

Teleflex has direct overlap with ICU Medical's Smiths Medical-acquired Portex airway management and Bivona tracheostomy tube lines, and competes in vascular access and pain management. Its comparable hospital-channel model and product breadth in respiratory make it a relevant comparable.

TypeDirect peer
Description

Baxter competes directly with ICU Medical across large-volume IV pumps (Sigma Spectrum), IV solutions, and infusion consumables. The Otsuka JV specifically targets the IV solutions market where Baxter is a dominant incumbent, making Baxter the most relevant peer for IV fluids manufacturing and supply.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ICU Medical

Medical Devicesicumed.com

What ICU Medical does

ICU Medical, Inc. (NASDAQ: ICUI) is a publicly traded medical device company founded in 1984 and headquartered in San Clemente, California, that develops, manufactures, and sells innovative medical technologies used in infusion therapy, vascular access, and adjacent clinical care areas. The company's portfolio spans nine product categories: infusion therapy (Plum large-volume pumps, CADD ambulatory pumps, Medfusion syringe pumps, IV consumables, vascular access devices, IV solutions); pharmacy preparation (ChemoLock and ChemoClave closed system transfer devices, Diana compounding workflow, PharmAssist peristaltic pumps); infusion safety software (LifeShield, PharmGuard, MedNet); airway management (Portex, Bivona tracheostomy tubes, ventilation, anesthesia, respiratory); temperature management (Hotline and Level 1 blood/fluid warmers); hemodynamic monitoring (Cogent 2-in-1 system, CardioFlo sensors, SafeSet blood sampling); renal care (ClearGuard antimicrobial caps, Tego connectors); pain management (EchoGlo nerve block kits, NRFit components); and veterinary/OEM. The technical foundation centers on needlefree connector engineering (Clave family), closed system mechanical barrier technology for hazardous drug handling, and IV-EHR interoperable pump-software architecture under the IV Performance Platform. The combined entity following the January 2022 Smiths Medical acquisition (~$2.35B from Smiths Group) operates manufacturing and direct sales in nine countries.

ICU Medical firmographics

Firmographics
Name
ICU Medical
Legal name
ICU Medical, Inc.
Website
https://icumed.com
Company type
Public
Founded year
1984
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

ICU Medical industry classification

Industry
Product category
Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Infusion Pumps (Ambulatory/Stationary) (HLAHAIAF)
akta.pro secondary industries
Infusion Sets, Catheters & Pump Consumables (HLAHAIAH), Wearable Injectors & On-Body Delivery Systems (HLAHAIAE)

Keywords

  • Infusion therapy devices
  • IV medical devices
  • Vascular access products
  • Medical consumables
  • Clinical infusion pumps

Where ICU Medical is headquartered

Location

Headquarters

HQ city
San Clemente
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ICU Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Devices - Hardware Sales: ICU Medical generates revenue from selling infusion pumps, IV equipment, vascular access devices, and other medical hardware. Products include Plum large-volume pumps, CADD ambulatory pumps, Medfusion syringe pumps, and related capital equipment.
  2. Single-Use Disposables and Consumables: The company derives significant revenue from recurring consumables including IV sets, connectors, disinfecting caps, administration sets, and other single-use products. Approximately 87% of revenue comes from single-use disposable items according to CEO presentation.
  3. Infusion Safety Software: Revenue from software licenses including LifeShield Infusion Safety Software, PharmGuard Infusion Management System, and MedNet IV medication safety software for hospitals
  4. Temperature Management Products: Sales of blood and fluid warming systems including Hotline products and Level 1 warming devices along with associated disposable sets
  5. IV Solutions: Following completion of joint venture with Otsuka in May 2025, the company participates in IV solutions manufacturing through the JV entity Otsuka ICU Medical LLC

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

ICU Medical product offering

Product offering

Core offering

ICU Medical develops, manufactures, and sells medical devices and consumables for infusion therapy, including large-volume IV pumps, ambulatory and syringe pumps, needlefree IV connectors, closed system transfer devices for hazardous drug handling, infusion safety software, temperature management systems, airway management products, hemodynamic monitoring systems, and renal care products. Approximately 87% of revenue comes from single-use disposable items, with the remaining from capital equipment and software licenses sold primarily to hospitals, health systems, and clinical facilities.

Product overview

ICU Medical offers a comprehensive, multi-category medical device portfolio organized into nine core product lines: Infusion Therapy (large-volume pumps, ambulatory pumps, syringe pumps, IV consumables, vascular access, IV solutions), Pharmacy Preparation (closed system transfer devices, compounding automation, infusion safety software), Airway Management (tracheostomy, respiratory, anesthesia, ventilation), Temperature Management (blood/fluid warmers, convective warming), Hemodynamic Monitoring (monitoring systems, sensors, blood pressure), Renal Care (antimicrobial caps, connectors), Pain Management (regional anesthesia, nerve blocks, spinal/epidural), Veterinary, and OEM. The flagship IV Performance Platform integrates Plum Duo™ and Plum Solo™ precision IV pumps with LifeShield™ software for IV-EHR interoperability. The company serves acute care, home care, pharmacy, and veterinary settings through both organic development and the 2022 Smiths Medical acquisition which expanded the portfolio with CADD pumps, Medfusion syringes, and Portex/Bivona airway products.

Differentiator

Problem solved

Functional benefit

Brands

  • Plum: Large-volume IV infusion pumps including Plum Duo and Plum Solo precision pumps
  • CADD
  • LifeShield
  • ChemoLock
  • ChemoClave
  • Portex
  • Bivona
  • Hotline
  • Level 1
  • SafeSet
  • ClearGuard
  • Tego
  • Diana
  • Medfusion

Products and services

  • Plum Solo Precision IV Pump
  • Plum Duo Precision IV Pump
  • Plum 360 Large Volume Infusion Pump
  • CADD-Solis Infusion System
  • CADD-Solis VIP Ambulatory Home Infusion System
  • Medfusion Syringe Pumps
  • Clave Needlefree IV Connectors
  • ChemoLock Needlefree Closed System Transfer Device (CSTD)
  • ChemoClave Needlefree Closed System Transfer Device (CSTD)
  • Diana Compounding Workflow System
  • PharmAssist Pro Peristaltic Pump
  • LifeShield Infusion Safety Software
  • ICU Medical MedNet IV Medication Safety Software
  • PharmGuard Infusion Management System
  • Level 1 H-1200 Fast Flow Fluid Warmer
  • Hotline 3 Blood and Fluid Warmer
  • Hotline Blood and Fluid Warmer
  • Portex BLUselect Tracheostomy Tubes
  • Bivona Silicone Tracheostomy Tubes
  • Cogent 2-in-1 Hemodynamic Monitoring System
  • CardioFlo Hemodynamic Monitoring Sensor
  • SafeSet Blood Sampling System
  • ClearGuard HD Antimicrobial Barrier Caps
  • Tego Needlefree Hemodialysis Connector
  • EchoGlo Peripheral Nerve Block Kits and Trays
  • NRFit Components
  • MyAcapella Digital OPEP Coach
  • IV Performance Platform
  • SurgiVet Advisor Tech Vital Signs Monitor

Quantifiable outcome

  • 30% reduction in clinical medication errors through ready-to-administer formats
  • +3 more outcomes

Companies that use ICU Medical

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles3 records

ICU Medical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

ICU Medical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Otsuka Pharmaceutical Factory, Inc.coreStrategic or Co-development Partner · 1 May 2025ICU Medical and Otsuka Pharmaceutical Factory completed a joint venture to bolster IV solutions manufacturing and innovation in North America. The partnership creates one of the largest global IV solutions manufacturing networks with combined production of approximately 1.4 billion annual units. The JV entity is named Otsuka ICU Medical LLC and aims to bring additional supply chain resiliency and new innovation to the North American IV solutions market.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

ICU Medical competitors and assessment

Company assessment

Direct peers

  • Becton, Dickinson and Company (BD): BD is the largest direct competitor in IV therapy, vascular access, and infusion consumables. BD's Medical segment competes head-to-head with ICU Medical's Clave connectors, IV sets, and infusion platforms, making it the closest peer for share, scale, and pricing dynamics in hospital infusion.
  • Fresenius Kabi: Fresenius Kabi is a global manufacturer of infusion pumps (Agilia family), IV consumables, and specialty injectable drugs. It is a direct competitor to ICU Medical in hospital infusion and is increasingly expanding its pump and consumables portfolio in North America following its Ivenix acquisition.
  • B. Braun: B. Braun is a privately held global leader in infusion therapy (Infusomat pumps, IV sets, needlefree connectors) and competes directly with ICU Medical across infusion pumps, consumables, and pharmacy preparation. Its broad hospital-focused portfolio and global footprint make it a close comparable on scale and product breadth.
  • Terumo: Terumo competes with ICU Medical in infusion systems (Terufusion), syringes, and vascular access. Its hospital-focused medical device business and growing presence in infusion safety software make it a strong comparable for ICU Medical's premium pump and consumables strategy.
  • Nipro Corporation: Nipro manufactures infusion sets, syringes, dialysis products, and other hospital medical devices, overlapping directly with ICU Medical's IV consumables, renal care, and vascular access portfolios. Its scale and emerging US footprint make it a relevant direct peer.
  • Teleflex: Teleflex has direct overlap with ICU Medical's Smiths Medical-acquired Portex airway management and Bivona tracheostomy tube lines, and competes in vascular access and pain management. Its comparable hospital-channel model and product breadth in respiratory make it a relevant comparable.
  • Baxter International: Baxter competes directly with ICU Medical across large-volume IV pumps (Sigma Spectrum), IV solutions, and infusion consumables. The Otsuka JV specifically targets the IV solutions market where Baxter is a dominant incumbent, making Baxter the most relevant peer for IV fluids manufacturing and supply.

Broad incumbents

  • Medtronic: Medtronic is a diversified medical device leader with limited overlap in infusion but a comparable scale, hospital-channel presence, and R&D footprint. It is a relevant broader incumbent for benchmarking margins, capital allocation, and global hospital sales execution.
  • Cardinal Health: Cardinal Health is a major medical product distributor and manufacturer with hospital channel reach. While it operates at a different layer of the value chain, it is comparable as a broad incumbent that supplies IV-related consumables and competes for hospital supply contracts.
  • Smiths Group plc: Smiths Group divested Smiths Medical to ICU Medical in 2022, so it is no longer a direct peer in medical devices, but it remains comparable as the former parent of ICU Medical's largest business segment and as a UK-listed diversified industrial with medical exposure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

ICU Medical social profiles

Digital presence

ICU Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ICU Medical leadership team

Management profile

Number of profiles

Profiles4 records

ICU Medical subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

ICU Medical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ICU Medical M&A and investment

M&A and investment

M&A6 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ICU Medical

What does ICU Medical do?

ICU Medical develops, manufactures, and sells medical devices and consumables for infusion therapy, including large-volume IV pumps, ambulatory and syringe pumps, needlefree IV connectors, closed system transfer devices for hazardous drug handling, infusion safety software, temperature management systems, airway management products, hemodynamic monitoring systems, and renal care products. Approximately 87% of revenue comes from single-use disposable items, with the remaining from capital equipment and software licenses sold primarily to hospitals, health systems, and clinical facilities.

Is ICU Medical a public or private company?

ICU Medical is a public company. It is classified as public and is currently operating.

When was ICU Medical founded?

ICU Medical was founded in 1984. It employs 1,001 to 5,000 people.

Where is ICU Medical based?

ICU Medical is headquartered in San Clemente, United States, in the North America region.

How does ICU Medical make money?

Five revenue lines are on record. Medical Devices - Hardware Sales are the primary driver. The others are single-Use Disposables and Consumables, infusion Safety Software, temperature Management Products and IV Solutions.

Who are ICU Medical's main competitors?

Direct peers on record are Becton, Dickinson and Company (BD), Fresenius Kabi, B. Braun, Terumo, Nipro Corporation, Teleflex and Baxter International. Broad incumbents are Medtronic, Cardinal Health and Smiths Group plc.

Does ICU Medical have an API?

No public API is recorded for ICU Medical.

What industry is ICU Medical in?

ICU Medical's product category is Medical Devices. Its primary akta.pro industry code is HLAHAIAF, Infusion Pumps (Ambulatory/Stationary), with a secondary code of HLAHAIAH, Infusion Sets, Catheters & Pump Consumables. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StICU Medical (ICUI), What Is Behind The Fresh Attention?ICU Medical faced two FDA Class II voluntary recalls for administration sets and medication cassette reservoirs, raising product safety concerns. The stock has returned 1.27% in one day and 6.26% over 90 days, with a year-to-date gain of 16.51%. Analysts peg fair value at $191.50, implying undervaluation, though recall risk and thin net income remain concerns.Defense WorldICU Medical, Inc. (NASDAQ:ICUI) Receives Consensus Recommendation of “Moderate Buy” from AnalystsAnalysts have assigned ICU Medical an average rating of "Moderate Buy" with a 12-month price target of $192.80. The company reported Q2 EPS of $2.37, beating estimates of $1.91, and revenue of $547.88 million, up 0.5% year-over-year. Insiders sold 21,830 shares over the last quarter.MarketBeatICU Medical, Inc. (NASDAQ:ICUI) Receives Consensus Recommendation of "Moderate Buy" from AnalystsAnalysts have assigned ICU Medical an average rating of Moderate Buy, with a 12-month price target of $192.80. The company reported Q2 EPS of $2.37, beating estimates, and set FY2026 guidance of 8.60-9.00 EPS. Insiders sold 21,830 shares over the last quarter.GurufocusA Look at ICU Medical Inc (ICUI) After 3.7% Gain -- GF Value $12ICU Medical Inc shares rose 3.7% to $160.98 on September 22, 2026, trading 32.6% above its GF Value estimate of $121.40. The stock's P/E of 136x exceeds its 5-year median of 88x, and insiders sold $8.3 million in shares over the past year.Simply Wall StIs ICU Medical (ICUI) Cheap After Its Veterinary IV Set Recall?ICU Medical voluntarily recalled 1,721,800 veterinary IV sets with drip chambers that may contain black specks, a Class II event. The recall follows a 30-day share price drop of 16.79% and insider sales, while the stock trades at a 127.1x P/E versus a peer average of 34.8x.YahooICU Medical CFO Sells 6,381 Shares for $1.1 MillionICU Medical CFO Brian Michael Bonnell sold 6,381 shares on Sept. 1, 2026, for $1.1 million under a Rule 10b5-1 plan. He retains 56,062 shares, valued at $9.5 million, while the company's market cap is $4.3 billion.YahooICU Medical CFO Brian Bonnell Sells 9,307 SharesICU Medical CFO Brian Bonnell sold 9,307 shares on Aug. 31, 2026, for $1.6 million. He holds 62,443 direct shares, valued at $10.8 million, after the sale. The stock had a 35% return over the one-period ending Aug. 31, 2026.The Motley FoolICU Medical CFO Brian Bonnell Sells 9,307 SharesICU Medical CFO Brian Bonnell sold 9,307 shares on Aug. 31, 2026, for $1.6 million under a Rule 10b5-1 plan. He retains 62,443 shares, valued at $10.8 million, representing about 0.2% of the company. Analysts rate the stock a buy with a median price target of $195.Seeking AlphaICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptICU Medical CEO Vivek Jain said at the Morgan Stanley conference that demand and utilization remain stable, with hospital admissions and census in line with guidance. He noted no slowdown from ACA subsidy expirations, and the rest of the year is expected to be consistent with current assumptions.Markets DailySquarepoint Ops LLC Takes Position in ICU Medical, Inc. $ICUISquarepoint Ops LLC acquired a new stake in ICU Medical, Inc. in Q2, purchasing 25,540 shares valued at about $3.74 million. Other institutional investors also moved positions, and the stock has a consensus "Moderate Buy" rating with a target price of $192.80.